Logo image of EXE.PA

EXEL INDUSTRIES SA-A SHS (EXE.PA) Stock Fundamental Analysis

Europe - EPA:EXE - FR0004527638 - Common Stock

35.7 EUR
-0.3 (-0.83%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

5

Overall EXE gets a fundamental rating of 5 out of 10. We evaluated EXE against 103 industry peers in the Machinery industry. EXE has an average financial health and profitability rating. EXE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

EXE had positive earnings in the past year.
EXE had a positive operating cash flow in the past year.
Of the past 5 years EXE 4 years were profitable.
EXE had a positive operating cash flow in 4 of the past 5 years.
EXE.PA Yearly Net Income VS EBIT VS OCF VS FCFEXE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

EXE has a Return On Assets of 3.51%. This is comparable to the rest of the industry: EXE outperforms 57.28% of its industry peers.
The Return On Equity of EXE (6.73%) is comparable to the rest of the industry.
The Return On Invested Capital of EXE (6.89%) is better than 65.05% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EXE is in line with the industry average of 8.61%.
The last Return On Invested Capital (6.89%) for EXE is above the 3 year average (6.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.51%
ROE 6.73%
ROIC 6.89%
ROA(3y)3.83%
ROA(5y)3.13%
ROE(3y)7.71%
ROE(5y)6.23%
ROIC(3y)6.68%
ROIC(5y)6.61%
EXE.PA Yearly ROA, ROE, ROICEXE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

With a Profit Margin value of 2.83%, EXE perfoms like the industry average, outperforming 46.60% of the companies in the same industry.
In the last couple of years the Profit Margin of EXE has grown nicely.
EXE's Operating Margin of 5.13% is in line compared to the rest of the industry. EXE outperforms 46.60% of its industry peers.
EXE's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 47.00%, EXE is doing good in the industry, outperforming 63.11% of the companies in the same industry.
In the last couple of years the Gross Margin of EXE has grown nicely.
Industry RankSector Rank
OM 5.13%
PM (TTM) 2.83%
GM 47%
OM growth 3Y-6.28%
OM growth 5Y4%
PM growth 3Y-17.01%
PM growth 5Y39.98%
GM growth 3Y-0.94%
GM growth 5Y7.12%
EXE.PA Yearly Profit, Operating, Gross MarginsEXE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXE is destroying value.
Compared to 1 year ago, EXE has about the same amount of shares outstanding.
EXE has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, EXE has an improved debt to assets ratio.
EXE.PA Yearly Shares OutstandingEXE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
EXE.PA Yearly Total Debt VS Total AssetsEXE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

EXE has an Altman-Z score of 2.83. This is not the best score and indicates that EXE is in the grey zone with still only limited risk for bankruptcy at the moment.
EXE has a better Altman-Z score (2.83) than 68.93% of its industry peers.
EXE has a debt to FCF ratio of 9.26. This is a negative value and a sign of low solvency as EXE would need 9.26 years to pay back of all of its debts.
The Debt to FCF ratio of EXE (9.26) is worse than 61.16% of its industry peers.
EXE has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of EXE (0.16) is better than 73.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 9.26
Altman-Z 2.83
ROIC/WACC0.99
WACC6.95%
EXE.PA Yearly LT Debt VS Equity VS FCFEXE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

EXE has a Current Ratio of 1.75. This is a normal value and indicates that EXE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.75, EXE is in the better half of the industry, outperforming 62.14% of the companies in the same industry.
A Quick Ratio of 0.82 indicates that EXE may have some problems paying its short term obligations.
With a Quick ratio value of 0.82, EXE is not doing good in the industry: 63.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 0.82
EXE.PA Yearly Current Assets VS Current LiabilitesEXE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2

3. Growth

3.1 Past

The earnings per share for EXE have decreased strongly by -26.98% in the last year.
The Earnings Per Share has been growing by 50.29% on average over the past years. This is a very strong growth
Looking at the last year, EXE shows a small growth in Revenue. The Revenue has grown by 0.46% in the last year.
EXE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.19% yearly.
EPS 1Y (TTM)-26.98%
EPS 3Y-10.42%
EPS 5Y50.29%
EPS Q2Q%-33.9%
Revenue 1Y (TTM)0.46%
Revenue growth 3Y7.83%
Revenue growth 5Y7.19%
Sales Q2Q%-0.76%

3.2 Future

The Earnings Per Share is expected to decrease by -1.53% on average over the next years.
Based on estimates for the next years, EXE will show a decrease in Revenue. The Revenue will decrease by -1.15% on average per year.
EPS Next Y-36.34%
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%
EPS Next 5YN/A
Revenue Next Year-8.38%
Revenue Next 2Y-3.53%
Revenue Next 3Y-1.15%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EXE.PA Yearly Revenue VS EstimatesEXE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
EXE.PA Yearly EPS VS EstimatesEXE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.76, which indicates a rather cheap valuation of EXE.
94.17% of the companies in the same industry are more expensive than EXE, based on the Price/Earnings ratio.
EXE is valuated cheaply when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 11.94, the valuation of EXE can be described as very reasonable.
EXE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXE is cheaper than 67.96% of the companies in the same industry.
EXE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.94.
Industry RankSector Rank
PE 7.76
Fwd PE 11.94
EXE.PA Price Earnings VS Forward Price EarningsEXE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXE is valued cheaper than 87.38% of the companies in the same industry.
EXE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EXE is cheaper than 69.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.55
EV/EBITDA 4.31
EXE.PA Per share dataEXE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The decent profitability rating of EXE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.15
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.20%, EXE has a reasonable but not impressive dividend return.
EXE's Dividend Yield is rather good when compared to the industry average which is at 2.44. EXE pays more dividend than 87.38% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, EXE pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.2%

5.2 History

On average, the dividend of EXE grows each year by 6.63%, which is quite nice.
Dividend Growth(5Y)6.63%
Div Incr Years1
Div Non Decr Years1
EXE.PA Yearly Dividends per shareEXE.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

EXE pays out 34.22% of its income as dividend. This is a sustainable payout ratio.
DP34.22%
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%
EXE.PA Yearly Income VS Free CF VS DividendEXE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M
EXE.PA Dividend Payout.EXE.PA Dividend Payout, showing the Payout Ratio.EXE.PA Dividend Payout.PayoutRetained Earnings

EXEL INDUSTRIES SA-A SHS

EPA:EXE (10/17/2025, 7:00:00 PM)

35.7

-0.3 (-0.83%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-23 2025-07-23
Earnings (Next)10-24 2025-10-24
Inst Owners7.89%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap242.40M
Analysts48.89
Price Target41.48 (16.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.2%
Yearly Dividend1.57
Dividend Growth(5Y)6.63%
DP34.22%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-45.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.13%
Valuation
Industry RankSector Rank
PE 7.76
Fwd PE 11.94
P/S 0.22
P/FCF 12.55
P/OCF 4.89
P/B 0.52
P/tB 0.65
EV/EBITDA 4.31
EPS(TTM)4.6
EY12.89%
EPS(NY)2.99
Fwd EY8.37%
FCF(TTM)2.84
FCFY7.97%
OCF(TTM)7.3
OCFY20.44%
SpS161.9
BVpS68.21
TBVpS54.64
PEG (NY)N/A
PEG (5Y)0.15
Profitability
Industry RankSector Rank
ROA 3.51%
ROE 6.73%
ROCE 9.89%
ROIC 6.89%
ROICexc 7.56%
ROICexgc 9.18%
OM 5.13%
PM (TTM) 2.83%
GM 47%
FCFM 1.76%
ROA(3y)3.83%
ROA(5y)3.13%
ROE(3y)7.71%
ROE(5y)6.23%
ROIC(3y)6.68%
ROIC(5y)6.61%
ROICexc(3y)7.49%
ROICexc(5y)7.69%
ROICexgc(3y)9.26%
ROICexgc(5y)9.78%
ROCE(3y)9.59%
ROCE(5y)9.66%
ROICexcg growth 3Y-11.14%
ROICexcg growth 5Y6.57%
ROICexc growth 3Y-8.43%
ROICexc growth 5Y6.79%
OM growth 3Y-6.28%
OM growth 5Y4%
PM growth 3Y-17.01%
PM growth 5Y39.98%
GM growth 3Y-0.94%
GM growth 5Y7.12%
F-Score7
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 9.26
Debt/EBITDA 0.87
Cap/Depr 100.15%
Cap/Sales 2.75%
Interest Coverage 6.24
Cash Conversion 57.19%
Profit Quality 61.97%
Current Ratio 1.75
Quick Ratio 0.82
Altman-Z 2.83
F-Score7
WACC6.95%
ROIC/WACC0.99
Cap/Depr(3y)92.15%
Cap/Depr(5y)79.17%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.98%
EPS 3Y-10.42%
EPS 5Y50.29%
EPS Q2Q%-33.9%
EPS Next Y-36.34%
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%
EPS Next 5YN/A
Revenue 1Y (TTM)0.46%
Revenue growth 3Y7.83%
Revenue growth 5Y7.19%
Sales Q2Q%-0.76%
Revenue Next Year-8.38%
Revenue Next 2Y-3.53%
Revenue Next 3Y-1.15%
Revenue Next 5YN/A
EBIT growth 1Y-15.46%
EBIT growth 3Y1.06%
EBIT growth 5Y11.48%
EBIT Next Year24.32%
EBIT Next 3Y12.01%
EBIT Next 5YN/A
FCF growth 1Y-69.03%
FCF growth 3Y-25.63%
FCF growth 5Y-8.04%
OCF growth 1Y-40.05%
OCF growth 3Y-7.67%
OCF growth 5Y4.57%